PepDiana
Back to Evidence
Primary experimental recordNegative / threshold

PMC12474311::ACT027069

NY-ESO-1 157-165 epitope

Evidence text

Paper-level observation

The activities were most potent for HLA-A*02:01, HLA-A*02:10, HLA-A*02:03, and HLA-A*02:06 but not for HLA-A*02:05 (Section 3.4, Figure 4a).
textConfidence: medium

Assay observation

Activity
Immunomodulatory
Subtype
T-cell activation
Measure
qualitative
Comparator
=
Raw observation
not active
Normalized measurement
Not reported by source
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
586 mel-A*02:05
Assay method
Not reported by source
Sequence
SLLMWITQC
Standardization
ready simple

Source publication

TCR-T Cell Recognition of an NY-ESO-1 Epitope Presented by HLA-A2 Supertype: Implications for Cancer Immunotherapy

Vaccines · 2025

DOI 10.3390/vaccines13090898 PMC12474311
Parent mention

Related peptide identities

PEPDIA-PLP-002699

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.